Notably, multiple preclinical studies have demonstrated that suppressing mutant HTT (mHTT) in the brain can improve and even reverse molecular, neuropathological and behavioural abnormalities in various rodent models of HD (16–28). The gene discussed is HTT; the disease is Huntington disease.